DBV Technologies (DBVT) Asset Utilization Ratio (2021 - 2026)
DBV Technologies (DBVT) posted quarterly Asset Utilization Ratio of 0.02 for Q2 2026, down 49.42% year-on-year from 0.04 in Q2 2025, and down 11.9% on a QoQ basis from 0.02 in Q1 2026.
DBV Technologies (DBVT) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Asset Utilization Ratio for 6 consecutive years, with 0.02 the latest figure, recorded in Q2 2026.
- Quarterly Asset Utilization Ratio fell 49.42% year-over-year to 0.02 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.02 (down 49.42% YoY) and the FY2025 annual result came in at 0.04, up 11.46% from the prior year.
- Asset Utilization Ratio retreated to 0.02 in Q2 2026 per DBVT's latest filing, from 0.02 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for DBVT reached as high as 0.12 in Q3 2024 and fell as low as 0.02 in Q1 2023.
- A 5-year average of 0.05 and a median of 0.04 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio sank 70.12% — and 2024, when it soared 384.81%.
- Year by year, Asset Utilization Ratio stood at 0.02 in 2022, then jumped by 330.78% to 0.08 in 2023, then tumbled by 37.28% to 0.05 in 2024, then plunged by 37.21% to 0.03 in 2025, then slumped by 38.3% to 0.02 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.02, 0.02, and 0.03 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.06 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.11 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.08 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.02 |